North America HER2 Antibodies Market is witnessing robust growth, driven by the high incidence of HER2-positive cancers, strong adoption of personalized medicine, and continuous innovation in oncology therapeutics. The country's well-established biotechnology and pharmaceutical industry, extensive clinical research ecosystem, and increasing investments in immuno-oncology are contributing to the...